HWKN Earnings Date: Jan 27, 2027 (Estimated) — Hawkins, Inc.
NASDAQ · Materials · Specialty Chemicals
Updated
When is HWKN's next earnings date?
Hawkins, Inc. (HWKN) is expected to report Q3 2027 earnings on Wednesday, January 27, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.75 on revenue of $267.4M.
How did HWKN do in its last earnings report?
In its most recent report on Oct 26, 2026 (Q2 2027), Hawkins, Inc. posted EPS of $1.34 versus the $1.25 estimate, a beat of 7.2%. Revenue was $313.8M against a $302.7M estimate. The stock's 1-day post-earnings move was +13.6%.
How much does HWKN stock move after earnings?
HWKN beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.2% (up or down) in the day after earnings.
About Hawkins, Inc.
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.
🤖 AI Earnings Analysis
Hawkins delivered a solid specialty-chemicals quarter, with revenue up 12% to $314 million and EPS rising 24% to $1.34, beating estimates by $0.09. The $0.20 dividend underscores confidence, though growth appears steady rather than accelerating.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-26 | Q2 2027 | 1.25 | 1.34 | +7.20% | $313.8M | ✅ Beat | +13.59% | — | — |
| 2026-07-29 | Q1 2027 | 1.51 | 1.35 | -10.60% | $315.7M | ❌ Miss | -6.76% | -2.38% | -14.97% |
| 2026-05-13 | Q4 2026 | 0.70 | 0.74 | +5.71% | $265.9M | ✅ Beat | -3.25% | -4.16% | -2.04% |
| 2026-01-28 | Q3 2026 | 0.73 | 0.69 | -5.48% | $244.1M | ❌ Miss | -9.12% | -15.92% | -2.90% |
| 2025-10-29 | Q2 2026 | 1.23 | 1.08 | -12.20% | $280.4M | ❌ Miss | -5.04% | -19.62% | -17.89% |
| 2025-07-30 | Q1 2026 | 1.34 | 1.40 | +4.48% | $293.3M | ✅ Beat | +2.59% | +7.17% | +6.82% |
| 2025-01-29 | Q3 2025 | 0.92 | 0.72 | -21.74% | $226.2M | ❌ Miss | -8.44% | -2.58% | -9.43% |
| 2024-10-30 | Q2 2025 | 1.18 | 1.16 | -1.69% | $247.0M | ❌ Miss | -8.86% | +2.21% | +14.84% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY27 · $112.9M total
| Segment | Share | Revenue | YoY | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|
| Nutrition | 31.7% | $35.8M | +7.2% | — | $35.3M | $33.4M | $24.6M |
| Bulk products | 28.4% | $32.1M | +33.7% | — | $23.8M | $24.0M | $23.3M |
| Food | 22.4% | $25.3M | +3.0% | — | $26.1M | $24.5M | $29.2M |
| Agricultural | 6.6% | $7.4M | -3.4% | — | $21.5M | $7.7M | $8.4M |
| Pharmaceutical | 6.2% | $7.1M | +5.8% | — | $5.6M | $6.7M | $7.3M |
| Other | 4.6% | $5.2M | +67.3% | $3.4M | $3.4M | $3.1M | $3.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.